Skip to main content
. 2021 Dec 24;2:99–106. doi: 10.1016/j.ijregi.2021.12.009

Figure 3.

Figure 3

Graphical representation of patients with rhino-orbito-cerebral mucormycosis during recovery after coronavirus disease 2019 (COVID-19) versus those with ongoing COVID-19.